Giga-tronics Incorporated (OTCQB: GIGA) (the “Company”) reported net revenue for the fourth fiscal quarter ended March 30, 2019 of $3.5 million, a 50% increase as compared to $2.3 million for the same period of fiscal 2018. […]
– Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 –
[…]
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue” or “the Company”) (TSXV:CBLU) (FRANKFURT:0YA) announced today the launch of its Energy-as-a-Service (EaaS) for wireless power. This new subscription-based service provides […]
Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab’s application is currently “In Progress” to obtain a Cannabis Licence (Processing- Standard, Federal […]
Multi-Center Phase III trial planned for 2019
[…]
PRINCETON, NJ – May 14, 2019 – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical […]
Key Company Highlights:*Providing Agricultural and Cultivation Solutions to Farmers*Infrastructure Maintenance and Cleaning Solutions to Mining sector*Preventing Water Contamination*Retail Opportunities INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street this is Juan Costello, Senior Analyst with the […]
INTERVIEW HIGHLIGHTS: *Two Pivotal Phase III studies for T-cell Lymphoma and Oral mucositis *Enrollment milestone for SGX942 *Upcoming interim analysis for SGX942 in September *Top-line final results for CTCL expected in 1Q 2020 INTERVIEW SUMMARY: […]
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com
